The authors comment on a study which offered a retrospective analysis of intravenous glucose tolerance test (IVGTT) data from oral insulin trial participants from the Diabetes Prevention Trial-Type 1 (DPT-1) who developed diabetes during follow-up. An overview of the observations regarding first-phase insulin response (FPIR) in the trial participants is provided.